Cargando…

An immunohistochemical study of the granulysin expression of 6 types of proven adverse cutaneous drug reaction

Detalles Bibliográficos
Autores principales:	Weinborn, Marie, Barbaud, Annick, Truchetet, François, Beurey, Philippe, Germain, Lucie, Schmutz, Jean-Luc, Cribier, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128424/ http://dx.doi.org/10.1186/2045-7022-4-S3-P3

Ejemplares similares

Granulysin expression and granulysin-mediated apoptosis in the peripheral blood of osteoarthritis patients
por: Drvar, Vedrana, et al.
Publicado: (2022)

Analysis of cross-reactivity between radio -contrast media in 97 hypersensitivity reactions
por: Lerondeau, Berangere, et al.
Publicado: (2014)

Use of the Human Granulysin Transgenic Mice To Evaluate the Role of Granulysin Expression by CD8 T Cells in Immunity To Mycobacterium tuberculosis
por: Thakur, Preeti, et al.
Publicado: (2022)

Comparative Antimicrobial Activity of Granulysin against Bacterial Biothreat Agents
por: Endsley, Janice J, et al.
Publicado: (2009)

Antimicrobial Properties of an Immunomodulator - 15 kDa Human Granulysin
por: Wei, Hung-Mu, et al.
Publicado: (2016)

Cell Death Mechanisms at the Maternal-Fetal Interface: Insights into the Role of Granulysin
por: Veljkovic Vujaklija, Danijela, et al.
Publicado: (2012)

Contributions of IFN-γ and granulysin to the clearance of Plasmodium yoelii blood stage
por: Hojo-Souza, Natália Satchiko, et al.
Publicado: (2020)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Cutaneous Adverse Reactions of Amiodarone
por: Jaworski, Krzysztof, et al.
Publicado: (2014)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Perforin enhances the granulysin-induced lysis of Listeria innocua in human dendritic cells
por: Walch, Michael, et al.
Publicado: (2007)

Expression, processing and transcriptional regulation of granulysin in short-term activated human lymphocytes
por: Latinovic-Golic, Sonja, et al.
Publicado: (2007)

Lamotrigine-induced toxic epidermal necrolysis confirmed by in vitro granulysin and cytokine assays
por: Won, Ha-Kyeong, et al.
Publicado: (2014)

Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type
por: Lo Bello, Giuseppe, et al.
Publicado: (2018)

Conjugation of the 9-kDa Isoform of Granulysin with Liposomes Potentiates Its Cytotoxicity
por: Soler-Agesta, Ruth, et al.
Publicado: (2022)

Treatments for Severe Cutaneous Adverse Reactions
por: Cho, Yung-Tsu, et al.
Publicado: (2017)

Epidemiology of cutaneous adverse drug reactions
por: Mockenhaupt, M.
Publicado: (2017)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

Enhanced tuberculosis clearance through the combination treatment with recombinant adenovirus-mediated granulysin delivery
por: Hao, Ling, et al.
Publicado: (2020)

Elevated Granulysin Expression in Cytotoxic Lymphocytes from the Blood and Lesions of Patients with Lichen Planus
por: VIČIĆ, Marijana, et al.
Publicado: (2021)

DNA copy number variations in drug reaction with eosinophilia and systemic symptoms (DRESS) identifying 2 new candidates genes
por: Bursztejn, Anne-Claire, et al.
Publicado: (2014)

Causality Assessment of Cutaneous Adverse Drug Reactions
por: Son, Young-Min, et al.
Publicado: (2011)

Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014)

Unusual and Interesting Adverse Cutaneous Drug Reactions
por: Masatkar, Vaishali, et al.
Publicado: (2018)

Controversies in the Management of Cutaneous Adverse Drug Reactions
por: Manchanda, Yashpal, et al.
Publicado: (2018)

Genetic markers of severe cutaneous adverse reactions
por: Jung, Jae-Woo, et al.
Publicado: (2018)

The assessment of severe cutaneous adverse drug reactions
por: Copaescu, Ana M, et al.
Publicado: (2022)

Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
por: Miyagawa, Fumi, et al.
Publicado: (2021)

Dermoscopic Aspects of Cutaneous Adverse Drug Reactions
por: Rossi, Gabriela, et al.
Publicado: (2021)

Granulysin-Expressing CD4(+) T Cells as Candidate Immune Marker for Tuberculosis during Childhood and Adolescence
por: Mueller, Henrik, et al.
Publicado: (2011)

Granulysin expressed in a humanized mouse model induces apoptotic cell death and suppresses tumorigenicity
por: Hsiao, Ya-Wen, et al.
Publicado: (2016)

Gran1: A Granulysin-Derived Peptide with Potent Activity against Intracellular Mycobacterium tuberculosis
por: Noschka, Reiner, et al.
Publicado: (2021)

Improved Purification of Human Granzyme A/B and Granulysin Using a Mammalian Expression System
por: Rasi, Valerio, et al.
Publicado: (2022)

Vancomycin-Associated Spontaneous Cutaneous Adverse Drug Reactions
por: An, So-Yeon, et al.
Publicado: (2011)

Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions
por: Orime, Mari
Publicado: (2017)

Recent Advances in Severe Cutaneous Adverse Drug Reaction
por: Das, Sudip, et al.
Publicado: (2018)

An Update on Adverse Cutaneous Drug Reactions in HIV/AIDS
por: Hoosen, Koraisha, et al.
Publicado: (2019)

Cutaneous Adverse Reactions Associated with COVID-19 Vaccination
por: Jin, Hope, et al.
Publicado: (2023)

Cutaneous Adverse Reactions of Immunotherapy in Patients with Advanced Melanoma
por: Nikolaou, Vasiliki, et al.
Publicado: (2023)

Induction of Granulysin and Perforin Cytolytic Mediator Expression in 10-Week-Old Infants Vaccinated with BCG at Birth
por: Semple, Patricia L., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2d3t9c4gr107qpriuft42evm5a